Recombinant Human UPB1 (C-6His)(Cat. No.:C210) novoprotein
$150.00
In stock
SKU
C210
10μg: $150
50μg: $440
500μg: $1540
1mg: $2200
Description
Recombinant Human Beta-Ureidopropionase is produced by our E.coli expression system and the target gene encoding Met1-Glu384 is expressed with a 6His tag at the C-terminus.
Product Details
| Item | Details |
| Known As | Beta-Ureidopropionase; BUP-1; Beta-Alanine Synthase; N-Carbamoyl-Beta-Alanine Amidohydrolase; UPB1; BUP1 |
| Mol Mass | 44.22 KDa |
| APMol Mass | 42 KDa, reducing conditions |
| Formulation Description | Supplied as a 0.2 μm filtered solution of PBS, pH 7.4. |
| Endotoxin | < 1 EU/µg as determined by LAL test. |
| Storage | Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| Shipping | The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below. |
Background
β-Ureidopropionase is a cytoplasmic protein which belongs to the CN hydrolase family of BUP subfamily. β-Ureidopropionase binds one zinc ion per subunit, catalyzes the last step in the pyrimidine degradation pathway. β-Ureidopropionase can convert N-carbamyl-beta-aminoisobutyric acid and N-carbamyl-beta-alanine to beta-aminoisobutyric acid and beta-alanine, ammonia and carbon dioxide, respectively. The pyrimidine bases uracil and thymine are degraded via the consecutive action of dihydropyrimidine dehydrogenase (DHPDH), dihydropyrimidinase (DHP) and beta-ureidopropionase (UP) to beta-alanine and beta aminoisobutyric acid, respectively. Defects in β-Ureidopropionase are the cause of β-Ureidopropionase deficiency that is characterized by muscular hypotonia, dystonic movements, scoliosis, microcephaly and severe developmental delay.
MDSD
Reviews
Write Your Own Review
Related Products
Check items to add to the cart or
